Member Info for Timster

One VERY important point to consider with the Avacta test is that it is the only one that will use Affimers.

If you need to know how exquisitely selective they are then look at the data Avacta have provided around the ELISA test and the Bruker note for bams:

https://www.bruker.com/fileadmin/user_upload/8-PDF-Docs/Separations_MassSpectrometry/Literature/ApplicationNotes/1881181_MT-128_SARS-CoV-2_Antigen_Assay_ebook.pdf

https://avacta.com/alastair-smith-gives-more-detail-on-the-sars-cov-2-elisa-laboratory-test/

are you talking about this doggy?
https://www.bbc.co.uk/news/uk-54827965

is it medusa trying it on again?

@Amateur No the investor presentation q&a confirmed an Nda but Lso confirmed there would be an RNS when the 10k batch is done

Yes, see my earlier post:
its as simple as this we are waiting for clarification via RNS that the batch is ready. Then as per the investor presentation:

The Affimer based lateral flow test developed with Cytiva is in the process of technology transfer
to BBI Solutions.
This process involves scale-up of the manufacturing processes and optimisation of the
performance of devices manufactured with the scaled up processes; the first pilot batch
will be 10,000 units.

Clinical validation can only be conducted on devices made using the scaled-up process to
satisfy CE regulations.

We expect clinical validation to be completed in Q4 dependent on pilot batch availability.

The clinical validation and lay user studies are being designed with Liverpool School of Tropical
Medicine.

Completion of verification and validation will allow Avacta to self-certify for professional use,
and completion of the lay user study, will lead to an audit by AYacWa·V notified body for CE
marking for consumer use.

When the manufacturing development phase is completed and the pilot batch is
available, the timeline to clinical validation, CE marking and product launch will be
defined more precisely.

Big Al stated he will not rush this and risk failure

Is it us
will it be us
must be us
could it be us
can it be us
it might be us
it may be us
it probably is us

Or is it Chin-ah

I would bet 10 Avacta shares that he will say nothing new.

OR

he says it will be a new test and this board goes mental (again)
is it us
will it be us
must be us
could it be us
can it be us
it might be us
it may be us
it probably is us
or is it Chin-ah

A joke is right, this is what we are waiting for

its as simple as this we are waiting for clarification via RNS that the batch is ready. Then as per the investor presentation:

The Affimer based lateral flow test developed with Cytiva is in the process of technology transfer
to BBI Solutions.
This process involves scale-up of the manufacturing processes and optimisation of the
performance of devices manufactured with the scaled up processes; the first pilot batch
will be 10,000 units.

Clinical validation can only be conducted on devices made using the scaled-up process to
satisfy CE regulations.

We expect clinical validation to be completed in Q4 dependent on pilot batch availability.

The clinical validation and lay user studies are being designed with Liverpool School of Tropical
Medicine.

Completion of verification and validation will allow Avacta to self-certify for professional use,
and completion of the lay user study, will lead to an audit by AYacWa·V notified body for CE
marking for consumer use.

When the manufacturing development phase is completed and the pilot batch is
available, the timeline to clinical validation, CE marking and product launch will be
defined more precisely.

Big Al stated he will not rush this and risk failure

If we get an RNS confirming tech transfer maybe. But 4 weeks for validation is a bit tight. But then it goes on 4000 tests so who knows.

Don't engage, Don't engage, Don't engage, Don't engage, Don't engage, Don't engage, Don't engage, Don't engage, Don't engage, Don't engage, Don't engage, Don't engage,

have we had an RNS for 10k pilot batch?

is it us?

he's bailed, a joke said so...

do people not understand how google works?

no point speculating until we know definitively if its been produced or if there are issues.

We have been told there will be an RNS when created. So we wait.

few percent lost again, its the new pattern while they fill a million pound order

spot on

Once this is ready will will have an RNS and evaluation of the best UK lateral flow test will begin

??

https://www.letsgetchecked.com/gb/en/home-coronavirus-test/?imp=cpc&gclid=CjwKCAiAnIT9BRAmEiwANaoE1aZfuErBYc3l9wVaCB6p7PXM-ISbuOeo96x3CihP36rwSB1iPEArFBoCKe4QAvD_BwE

is it us?